Tight Intra-Operative Glucose Control During Coronary Artery Bypass Surgery

NCT00394303 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1400

Enrollment

OTHER

Sponsor class

Stopped Trial suspended on 26 February, following the publication of a trial with negative results (Ann Intern Med 146(4), 2007). Pending ethics committee re-approval.

Conditions

Coronary Artery Bypass

Interventions

DRUG: Intraoperative continuous insulin infusion
OTHER: Control

Sponsor

Rabin Medical Center